Brief: Orthofix Medical Q1 Sales USD 188.6 Million Vs. IBES Estimate USD 184.1 Million
07/05/2024 13:00
May 07 (Reuters) - Orthofix Medical Q1 adjusted EBITDA USD 8 million vs. IBES estimate USD 7.04 million. * Q1 gross margin 67.5%
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team